Its downregulation has been shown to mitigate myocardial ischemia, reperfusion injury, and cardiac hypertrophy post-acute myocardial infarction by influencing the miR-2054/AKT3 and miR-204-5p/LGALS3 pathways (56). This evidence concerns the gene LGALS3 and cardiac hypertrophy.